Energenesis Biomedical Presents ENERGI-Based Approach to Space Anemia at TASTI 2026
· prnewswire.com · popularity 16/100 · 0 similar stories today
Read the original at prnewswire.com →
Summary
Energenesis Biomedical (TWSE: 6657) presented at TASTI 2026 on Nov. 8 under the title "ATP: Powering Human Health Beyond Earth," in its first move into space biomedicine. The company is committed to developing an innovative solution for Space Anemia, a health risk for astronauts on...
Found in: PR Newswire. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 19.